Beam Therapeutics Inc.
BEAM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $282 | $436 | $233 | $560 |
| Short-Term Investments | $569 | $754 | $845 | $406 |
| Receivables | $0 | $0 | $0 | $300 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $27 | $21 | $15 | $7 |
| Total Curr. Assets | $878 | $1,211 | $1,093 | $1,273 |
| Property Plant & Equip (Net) | $216 | $238 | $234 | $187 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $9 | $11 | $15 | $14 |
| Total NC Assets | $226 | $249 | $249 | $201 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,104 | $1,460 | $1,342 | $1,474 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $9 | $7 |
| Short-Term Debt | $13 | $13 | $10 | $10 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $109 | $69 | $136 | $86 |
| Other Curr. Liab. | $56 | $122 | $68 | $110 |
| Total Curr. Liab. | $182 | $206 | $224 | $213 |
| LT Debt | $148 | $160 | $169 | $138 |
| Deferred Rev, NC | $33 | $110 | $202 | $262 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $3 | $14 | $34 |
| Total NC Liab. | $188 | $273 | $385 | $434 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $161 | $173 | $179 | $142 |
| Total Liabilities | $370 | $478 | $608 | $648 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$1,567 | -$1,190 | -$1,057 | -$768 |
| AOCI | $1 | $1 | -$2 | -$0 |
| Other Equity | $2,299 | $2,170 | $1,793 | $1,594 |
| Total Equity | $734 | $981 | $733 | $827 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,104 | $1,460 | $1,342 | $1,474 |
| Net Debt | -$121 | -$263 | -$54 | -$412 |